Additionally, VEGF was found to contribute to tumor growth [14], promote the mobilization of myeloid cells to the tumor area [45], modulate the innate immune response in GBM [46], and is associated with poor patient overall survival probability (Supplementary Figure S5). The gene discussed is VEGFA; the disease is glioblastoma.